MCID: LNG028
MIFTS: 59

Long Qt Syndrome malady

Categories: Genetic diseases, Rare diseases

Aliases & Classifications for Long Qt Syndrome

About this section

Aliases & Descriptions for Long Qt Syndrome:

Name: Long Qt Syndrome 10 21 45 22 47 12 36 65
Romano-Ward Syndrome 10 36 65
Long Q-T Syndrome 10 24
Long Qt Syndrome, Autosomal Dominant 22
Romano-Ward Long Qt Syndrome 22
 
Ward-Romano Syndrome 22
Romano Ward Syndrome 22
Lqt 10
Rws 22

Classifications:



External Ids:

Disease Ontology10 DOID:2843
ICD1027 I45.81
ICD9CM29 426.82
UMLS65 C0023976, C0035828

Summaries for Long Qt Syndrome

About this section
NIH Rare Diseases:45 Long qt syndrome is a disorder of the heart’s electrical activity that can cause sudden, uncontrollable, and irregular heartbeats (arrhythmia), which may lead to sudden death. long qt syndrome can be detected by electrocardiogram (ekg). it can be caused by a variety of different gene mutations (changes). it can also be acquired (noninherited) and may be brought on by certain medicines and other medical conditions. last updated: 10/4/2013

MalaCards based summary: Long Qt Syndrome, also known as romano-ward syndrome, is related to long qt syndrome 9 and long qt syndrome 15. An important gene associated with Long Qt Syndrome is KCNH2 (Potassium Voltage-Gated Channel Subfamily H Member 2), and among its related pathways are Interaction between L1 and Ankyrins and Role of Calcineurin-dependent NFAT signaling in lymphocytes. Affiliated tissues include heart, brain and testes, and related mouse phenotype muscle.

Disease Ontology:10 An autosomal genetic disease that is characterized by delayed repolarization of the heart following a heartbeat increases the risk of episodes of torsade de pointes (TDP, a form of irregular heartbeat that originates from the ventricles).

Wikipedia:68 Long QT syndrome (LQTS) is a rare inherited or acquired heart condition in which delayed repolarization... more...

GeneReviews summary for NBK1129

Related Diseases for Long Qt Syndrome

About this section

Diseases in the Long Qt Syndrome family:

Long Qt Syndrome 15 Long Qt Syndrome 9
Long Qt Syndrome-3 Long Qt Syndrome-11
Long Qt Syndrome 2 Long Qt Syndrome 1
Long Qt Syndrome-10 Long Qt Syndrome 13
Long Qt Syndrome 14 Long Qt Syndrome 12
Long Qt Syndrome 6 Long Qt Syndrome 5
Familial Long Qt Syndrome

Diseases related to Long Qt Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 612)
idRelated DiseaseScoreTop Affiliating Genes
1long qt syndrome 934.6CAV3, KCNJ2
2long qt syndrome 1534.3CALM1, CALM2, CALM3
3long qt syndrome 1433.7CALM1, CALM2, CALM3, RYR2, SCN5A
4jervell and lange-nielsen syndrome30.7AKAP9, ANK2, CALM1, CALM2, CAV3, KCNE1
5laryngotracheitis30.4CALM1, CALM2
6exostosis30.2CALM1, CALM2
7long qt syndrome 212.9
8long qt syndrome 612.8
9long qt syndrome 512.8
10long qt syndrome 1212.8
11long qt syndrome 112.8
12long qt syndrome 1312.8
13scn5a-related romano ward syndrome12.7
14familial long qt syndrome12.6
15timothy syndrome12.3
16andersen syndrome12.2
17long qt syndrome-312.2
18cardiac arrhythmia, ankyrin-b-related12.2
19long qt syndrome-1112.1
20long qt syndrome-1012.1
21ragweed sensitivity11.5
22andersen syndrome type 111.5
23prostatitis10.5
24leukemia10.5
25prostate cancer10.5
26arthritis10.5
27adenocarcinoma10.5
28ciliary dyskinesia, primary, 2610.4KCNE1, KCNH2
29endotheliitis10.4
30rheumatoid arthritis10.4
31breast cancer10.4
32hepatitis10.4
33neuronitis10.4
34lymphoma10.4
35pancreatitis10.4
36brugada syndrome 110.4KCNH2, SCN5A
37keratosis palmoplantaris striata10.4KCNH2, KCNJ2, KCNQ1
38colorectal cancer10.4
39melanoma10.4
40cerebritis10.4
41retinitis10.4
42phlegmonous dacryocystitis10.3CALM1, CALM2
43myocardial infarction10.3
44obesity10.3
45sarcoma10.3
46esophagitis10.3
47thyroiditis10.3
48cardiomyopathy10.3
49pleural empyema10.3CALM1, CALM2
50short qt syndrome 110.3CAV3, KCNH2

Graphical network of the top 20 diseases related to Long Qt Syndrome:



Diseases related to long qt syndrome

Symptoms for Long Qt Syndrome

About this section

Drugs & Therapeutics for Long Qt Syndrome

About this section

Drugs for Long Qt Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 180)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
IbutilideapprovedPhase 4, Phase 25122647-32-960753
Synonyms:
(+-)-4'-(4-(Ethylheptylamino)-1-hydroxybutyl)methanesulfoanilide (E)-2-butenedioate (2:1)
(+-)-4'-(4-(Ethylheptylamino)-1-hydroxybutyl)methanesulfonanilide fumarate (2:1) (salt)
(+-)-N-(4-(4-(Ethylheptylamino)-1-hydroxybutyl)phenyl)methanesulfonamide (E)-butenedioate
(E)-but-2-enedioic acid
122647-31-8
122647-31-8 (Parent)
122647-32-9
122647-32-9 (Fumarate)
130350-52-6
2C20H36N2O3S.C4H4O4
AC1L1TUW
AC1NQXZ2
AC1O5NJM
AC1Q6VUF
Butilide fumarate
C07753
C20H36N2O3S
CHEBI:112608
CHEMBL1200564
CHEMBL533
CID5281065
CID60753
CID6437366
Corvert
Corvert (TN)
D00648
D08060
DB00308
I06-1701
IBUTILIDE FUMARATE
Ibutilid
 
Ibutilida
Ibutilida [INN-Spanish]
Ibutilide
Ibutilide (INN)
Ibutilide Fumarate
Ibutilide Fumarate [USAN]
Ibutilide [BAN:INN]
Ibutilide [INN:BAN]
Ibutilide fumarate (USAN)
Ibutilidum
Ibutilidum [INN-Latin]
LS-172765
LS-90123
LS-90124
Methanesulfonamide, N-(4-(4-(ethylheptylamino)-1-hydroxybutyl)phenyl)-, (+-)-, (E)-2-butenedioate (2:1) (salt)
Methanesulfonamide, N-(4-(4-(ethylheptylamino)-1-hydroxybutyl)phenyl)-, (+-)-,(E)-2-butenedioate (2:1) (salt)
Methanesulfonamide, N-(4-(4-(ethylheptylamino)-1-hydroxybutyl)phenyl)-, (E)-2-butenedioate (2:1) (salt)
MolPort-005-932-621
N-(4-(4-(ethylheptylamino)-1-hydroxybutyl)phenyl)methanesulfonamide
N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide
N-[4-[4-[ethyl(heptyl)amino]-1-hydroxybutyl]phenyl]methanesulfonamide
NCGC00181771-01
U 70226E
U-70226E
U-82208E
U-82209E
U82208E
U82209E
UNII-2436VX1U9B
UNII-9L5X4M5L6I
ibutilide, (+-)-isomer
ibutilide, fumarate salt (2:1), (+-)-isomer
n-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide
2
Valproic Acidapproved, investigationalPhase 431199-66-13121
Synonyms:
(N-C3H7)2CHCOOH
(S)-2-propyl-4-pentanoate
(S)-2-propyl-4-pentanoic acid
2 PP (base)
2-N-Propyl-N-valeric acid
2-PROPYL-pentanoic acid
2-Propyl-Pentanoate
2-Propyl-Pentanoic acid
2-Propylpentanoate
2-Propylpentanoic Acid
2-Propylpentanoic acid
2-Propylvaleric Acid
2-Propylvaleric acid
2-n-Propyl-n-valeric acid
2-n-propyl-n-valeric acid
2-propylvaleric acid
4-Heptanecarboxylic acid
4-heptanecarboxylic acid
76584-70-8 (hydrochloride salt (2:1))
99-66-1
AC1L1F7T
AC1Q2ULA
AI3-10500
APO-divalproex
Abbott 44090
Acide valproique
Acide valproique [INN-French]
Acide valproique [inn-french]
Acido valproico
Acido valproico [INN-Spanish]
Acido valproico [inn-spanish]
Acidum valproicum
Acidum valproicum [INN-Latin]
Acidum valproicum [inn-latin]
Alti-Valproic
Alti-valproic
Apo-valproic
Apo-valproic syrup
Avugane
BIDD:GT0858
BRN 1750447
Baceca
C07185
CHEBI:39867
CHEMBL109
CID3121
CPD000499581
Convulex
Convulsofin
D00399
DB00313
DOM-divalproex
DOM-valproic
DOM-valproic acid E.C.
DPA
Delepsine
Depacon
Depakene
Depakene (TN)
Depakin
Depakin chrono
Depakine
Depakine chrono
Depakote
Depakote (TM)
Depakote ER
Deproic
Di-N-propylacetic acid
Di-N-propylessigsaeure
Di-N-propylessigsaure
Di-N-propylessigsaure [german]
Di-n-propylacetic acid
Di-n-propylessigsaeure
Di-n-propylessigsaure
Di-n-propylessigsaure [German]
Di-n-propylessigsäure
Dipropyl Acetate
Dipropylacetate
Dipropylacetic acid
DivK1c_000273
Divalproex
Dom-Valproic
Dom-valproate
Dom-valproic acid
Dom-valproic acid syrup
EINECS 202-777-3
Epiject I.V.
Epilex
Epilim
Epival
Epival er
Ergenyl
G2M-777
Gen-divalproex
HMS2089J06
HSDB 3582
I04-0211
InChI=1/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10)
KBio1_000273
KBio2_001001
KBio2_002277
KBio2_003569
KBio2_004845
 
KBio2_006137
KBio2_007413
KBio3_002626
KBio3_002757
KBioGR_000871
KBioGR_002277
KBioSS_001001
KBioSS_002278
Kyselina 2-propylvalerova
Kyselina 2-propylvalerova [Czech]
LS-161170
LS-2068
MLS001076682
MLS001335927
MLS001335928
MLS002415770
Med Valproic
Med valproic
MolPort-001-791-895
Mylproin
Myproate
Myproic Acid
Myproic acid
N-DPA
N-Dipropylacetic acid
NCGC00091149-01
NCGC00091149-02
NCGC00091149-03
NCGC00091149-04
NINDS_000273
NSC 93819
NSC93819
Novo-Valproic
Novo-Valproic - ECC
Novo-divalproex
Novo-valproic
Novo-valproic soft gel cap
Nu-Valproic
Nu-valproic
P0823
P6273_SIGMA
PEAC
PHL-valproate
PHL-valproic acid
PHL-valproic acid E.C.
PMS-Divalproex
PMS-Valproic Acid
PMS-valproate
PMS-valproic acid
PMS-valproic acid E.C.
Penta-Valproic
Penta-valproic
Propylvaleric acid
Ratio-Valproic - ECC
S(-)-4-En-valproate
S(-)-4-En-valproic acid
S-2-N-Propyl-4-pentenoate
S-2-N-Propyl-4-pentenoic acid
SAM002564230
SBB065764
SMR000499581
SPBio_000912
Sandoz valproic
Savicol
Semisodium Valproate
Sodium hydrogen divalproate
Spectrum2_000946
Spectrum3_001733
Spectrum4_000376
Spectrum_000521
Sprinkle
Stavzor
UNII-614OI1Z5WI
VALPROIC ACID
VALPROIC acid
VPA
Valcote
Valparin
Valproate
Valproate Semisodium
Valproate semisodique [French]
Valproate semisodium
Valproato semisodico [Spanish]
Valproatum seminatricum [Latin]
Valproic
Valproic Acid
Valproic Acid, Sodium Salt (2:1)
Valproic acid
Valproic acid (USP)
Valproic acid USP
Valproic acid USP24
Valproic acid [USAN:INN:BAN]
Valproic acid [usan:ban:inn]
Valproinsaeure
Valproinsäure
Vupral
WLN: QVY3 & 3
di-n-propylacetic acid
n-DPA
n-Dipropylacetic acid
nchembio.79-comp4
nchembio815-comp21
valproate
valproic acid
3
NorgestimateapprovedPhase 4, Phase 2, Phase 3, Phase 135135189-28-76540478
Synonyms:
(+)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one oxime acetate (ester)
(17-alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime
(17alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime
(3E)-17alpha-ethynyl-3-(hydroxyimino)-18a-homoestr-4-en-17beta-yl acetate
35189-28-7
AC-655
AC1O712U
C017576
CHEBI:50815
CHEMBL1200934
CID6540478
D 138
D-13beta-Ethyl-17alpha-ethynyl-17beta-acetoxygon-4-en-3-one oxime
D05209
DB00957
Dexnorgestrel Acetime
Dexnorgestrel acetime
I14-9729
 
LS-62080
NCGC00181353-01
NORGESTIMATE
Norgestimate (USP/INN)
Norgestimate [USAN:INN:BAN]
Norgestimato
Norgestimato [INN-Spanish]
Norgestimatum
Norgestimatum [INN-Latin]
ORF 10131
ORF-10131
Ortho-Prefest
RWJ 10131
RWJ-10131
UNII-C291HFX4DY
ZINC03938695
[(3E,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
d-13-beta-Ethyl-17-alpha-ethynyl-17-beta-acetoxygon-4-en-3-one oxime
d-13beta-Ethyl-17alpha-ethynyl-17beta-acetoxygon-4-en-3-one oxime
norgestrel oxime acetate
4
Moxifloxacinapproved, investigationalPhase 4, Phase 2, Phase 3, Phase 1409354812-41-2152946
Synonyms:
(1'S,6'S)-1-Cyclopropyl-7-(2,8-diazabicyclo[4.3.0]non-8-yl)-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylic acid
1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4as,7as)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylic acid
151096-09-2
186826-86-8
192927-63-2
7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid
AC1L49EP
Actira (*Hydrochloride*)
Avelox
Avelox (*Hydrochloride*)
Avelox I.V.
BAY 12-8039
BAY 12-8039 (*Hydrochloride*)
 
CCRIS 8690
CHEMBL32
CID152946
DB00218
I06-1961
LS-141510
MFX
MXF
MXFX
Moxeza
Moxifloxacin
Moxifloxacin Hydrochloride
Moxifloxacin [INN:BAN]
UNII-U188XYD42P
Vigamox
moxifloxacin
5
Estradiolapproved, investigationalPhase 4, Phase 2, Phase 3, Phase 1109450-28-25757, 53477783
Synonyms:
(+)-3,17b-Estradiol
(17b)-Estra-1,3,5(10)-triene-3,17-diol
(17beta)-Estra-1,3,5(10)-triene-3,17-diol
.alpha.-Estradiol
.alpha.-Oestradiol
.beta.-Estradiol
.beta.-Oestradiol
1,3,5[10]-Estratriene-3,17beta-diol 3-sulfate
1,3,5[10]-Estratriene-3,17beta-diol 3-sulphate
13b-Methyl-1,3,5(10)-gonatriene-3,17b-ol
17 beta-Estradiol
17-.BETA.-Estradiol
17-E
17-beta
17-beta-OH-estradiol
17-beta-estradiol
17.beta.-Estradiol
17.beta.-Oestradiol
17E
17b-Estradiol
17b-Oestradiol
17beta Oestradiol
17beta oestradiol
17beta-Estra-1,3,5(10)-triene-3,17-diol
17beta-Estradiol
17beta-Oestradiol
1jgl
1qkt
1qku
2d06
3,17-Epidihydroxyestratriene
3,17-beta-Estradiol
3,17-beta-Oestradiol
3,17.beta.-Estradiol
3,17b-Dihydroxyestra-1,3,5(10)-triene
3,17b-Estradiol
3,17beta-Estradiol
3,17beta-dihydroxy-1,3,5[10]-estratriene 3-sulfate
3,17beta-dihydroxy-1,3,5[10]-estratriene 3-sulphate
50-28-2
73459-61-7
873662-39-6
AC-10460
AC1L1L2K
Aerodiol
Agofollin
Alora
Altrad
Amnestrogen
Aquadiol
B-Estradiol
BEDOs
BIDD:ER0125
BIDD:PXR0065
BPBio1_000532
BSPBio_000482
BSPBio_001065
Bardiol
Benzhormovarine
Beta-estradiol
Bio-0812
Bio-E-Gel
Bio1_000403
Bio1_000892
Bio1_001381
Bio2_000363
Bio2_000843
C00951
C18H24O2
CCRIS 280
CHEBI:16469
CHEMBL135
CID5757
CMC_11154
CPD-352
CPD000059126
Climaderm
Climara
Climara (TN)
Climara Forte
Compudose
Compudose 200
Compudose 365
Corpagen
D-3,17beta-Estradiol
D-Estradiol
D-Oestradiol
D00105
DB00783
Depo-estradiol
Dermestril
Destradiol
Dihydro-Theelin
Dihydrofollicular hormone
Dihydrofolliculin
Dihydromenformon
Dihydrotheelin
Dihydroxyesterin
Dihydroxyestrin
Dihydroxyoestrin
Dimenformon
Diogyn
Diogynets
Divigel
Divigel (TN)
E 2
E 8875
E(sub 2)
E0025
E1024_SIGMA
E1132_SIGMA
E2257_SIGMA
E2758_SIGMA
E8875_SIGMA
EINECS 200-023-8
EU-0100503
Elestrin
Encore
Epiestriol 50
Esclim
Estra-1,3,5(10)-triene-3,17b-diol
Estrace
Estrace (TN)
Estraderm
Estraderm (TN)
Estraderm MX
Estraderm TTS
Estraderm TTS 100
Estraderm TTS 50
Estradiol
Estradiol Transdermal System
Estradiol Valerate
Estradiol [USAN:INN]
Estradiol acetate
Estradiol benzoate
Estradiol cypionate
Estradiol valerate
Estradiol-17 beta
Estradiol-17-beta
Estradiol-17.beta.
Estradiol-17beta
Estradiol-3,17beta
Estradiolo
Estradiolo [DCIT]
Estradiolum
Estradiolum [INN]
Estradot
Estraldine
Estrapak 50
Estrasorb
Estrasorb (TN)
Estreva
Estrifam
Estring
Estring (TN)
Estring Vaginal Ring
Estring vaginal ring
Estroclim
Estroclim 50
Estrodiolum
Estrofem 2
 
Estrofem Forte
Estrogel
Estrogel (TN)
Estrogel HBF
Estrovite
Evamist
Evorel
Extrasorb
Femanest
Femestral
Femestrol
Femogen
Fempatch
Femring
Femtrace
Femtran
Follicyclin
Gelestra
Ginedisc
Ginosedol
GynPolar
Gynergon
Gynestrel
Gynodiol
Gynoestryl
HMS1362E07
HMS1569I04
HMS1792E07
HMS1990E07
HMS2051C17
HMS2090E18
HSDB 3589
IDI1_002118
Innofem
Innofem (TN)
KBio2_000405
KBio2_002269
KBio2_002973
KBio2_004837
KBio2_005541
KBio2_007405
KBio3_000769
KBio3_000770
KBio3_002749
KBioGR_000405
KBioGR_002269
KBioSS_000405
KBioSS_002270
LMST02010001
LS-137
Lamdiol
Lio-Oid
Lopac0_000503
MLS000069494
MLS000758312
MLS001076331
Macrodiol
Macrol
Menest
Menorest
Menostar
Microdiol
Minivelle
MolPort-001-794-632
NCGC00091544-00
NCGC00091544-01
NCGC00091544-02
NCGC00091544-04
NCGC00091544-05
NCGC00091544-06
NCGC00091544-07
NCGC00091544-08
NCGC00091544-09
NCGC00091544-12
NCGC00179321-01
NCGC00179321-02
NSC-9895
NSC9895
Nordicol
Oesclim
Oestergon
Oestra-1,3,5(10)-triene-3,17b-diol
Oestradiol
Oestradiol Berco
Oestradiol R
Oestradiol-17-beta
Oestradiol-17.beta.
Oestradiol-17beta
Oestradiolum
Oestrogel
Oestroglandol
Oestrogynal
Ovahormon
Ovasterol
Ovastevol
Ovociclina
Ovocyclin
Ovocycline
Ovocylin
Perlatanol
Polyestradiol
Prestwick0_000441
Prestwick1_000441
Prestwick2_000441
Prestwick3_000441
Prestwick_207
Primofol
Profoliol
Profoliol B
Progynon
Progynon DH
Progynon-DH
S-21400
S1709_Selleck
SAM001247032
SK-Estrogens
SL-1100
SMP1_000121
SMR000059126
SPBio_002421
Sandrena 1
Sandrena Gel
Sisare Gel
Spectrum5_002055
Syndiol
Systen
Tradelia
Trial SAT
Trocosone
UNII-4TI98Z838E
VIVELLE-DOT
Vagifem
Vagifem (TN)
Vivelle
Vivelle (TN)
Vivelle Dot
Vivelle-dot
Zerella
Zesteem
Zesteen
Zumenon
[2,4,6,7-3H]-E2
[3H]-estradiol
[3H]]estradiol
b-Estradiol
beta-Estradiol
beta-Estradiol 3-sulfate
beta-Estradiol 3-sulphate
bmse000642
cMAP_000005
cis-Estradiol
cis-Oestradiol
component of Menrium
delta-Estradiol
delta-Oestradiol
estradiol
estradiol-17beta
nchembio.168-comp3
nchembio.76-comp2
nchembio775-comp2
nchembio794-comp6
nchembio860-comp1
progynon
6
Ethinyl EstradiolapprovedPhase 4, Phase 2, Phase 3, Phase 165957-63-65991
Synonyms:
17 alpha-Ethinylestradiol
17 alpha-Ethynylestradiol
17 alpha-Ethynyloestradiol
17 alpha-ethinyestradiol
17-Ethinyl-3,17-estradiol
17-Ethinyl-3,17-oestradiol
17-Ethinylestradiol
17-Ethynylestradiol
17-Ethynylestradiol ram
17-Ethynyloestradiol
17-alpha-Ethinyl-17-beta-estradiol
17-alpha-Ethynyl-17-beta-oestradiol
17-alpha-Ethynylestradiol
17-alpha-Ethynylestradiol-17-beta
17-alpha-ethynyl estradiol
17-ethinyl-3,17-estradiol
17-ethinyl-3,17-oestradiol
17-ethinylestradiol
17.alpha.-Ethinyl-17.beta.-estradiol
17.alpha.-Ethinylestradiol
17.alpha.-Ethynyl-17.beta.-oestradiol
17.alpha.-Ethynylestradiol
17.alpha.-Ethynylestradiol-l7.beta.
17.alpha.-Ethynyloestradiol
17.alpha.-Ethynyloestradiol-17.beta.
17a-Ethinyl-17b-estradiol
17a-Ethinylestradiol
17a-Ethynyl-17b-oestradiol
17a-Ethynylestradiol
17a-Ethynylestradiol-l7b
17a-Ethynyloestradiol
17a-Ethynyloestradiol-17b
17alpha-Ethinyl estradiol
17alpha-Ethinylestradiol
17alpha-Ethinylestradiol-17beta
17alpha-Ethynylestradiol
17alpha-Ethynyloestradiol
17alpha-Ethynyloestradiol-17beta
17α-ethynylestradiol
406932-93-2
46263_FLUKA
46263_RIEDEL
57-63-6
77538-56-8
AC-2169
AC1L1LK6
AI3-52941
Aethinyloestradiolum
Aethinyoestradiol
Aethinyoestradiol [German]
Alora
Amenoron
Amenorone
Anovlar
BIDD:ER0162
BRN 2419975
Bio-0610
C07534
CCRIS 286
CHEBI:4903
CHEMBL691
CID5991
CPD000058319
Certostat
Chee-O-Gen
Chee-O-Genf
Cyclosa
D004997
D00554
DB00977
Dicromil
Diognat-E
Diogyn E
Diogyn-E
Diprol
Dyloform
E4876_SIGMA
EE
EE(sub 2)
EE2
EINECS 200-342-2
EO
ETHINYLESTRADIOL
Effik Brand of Ethinyl Estradiol
Ertonyl
Esclim
Esteed
Estigyn
Estinyl
Estinyl (TN)
Eston-E
Estopherol
Estoral
Estoral (Orion)
Estoral (VAN)
Estoral [Orion]
Estoral {[Orion]}
Estorals
Estradiol, Ethinyl
Estradiol, Ethynyl
Estring
Estrogen
Ethidol
Ethinoral
Ethinyl E2
Ethinyl Estradiol Hemihydrate
Ethinyl Estradiol [USP]
 
Ethinyl Estradiol, (8 alpha)-Isomer
Ethinyl Oestradiol Effik
Ethinyl estradiol
Ethinyl estradiol (USP)
Ethinyl-Oestradiol Effik
Ethinyl-Oestranol
Ethinyl-oestranol
Ethinylestradiol
Ethinylestradiol (JP15/INN)
Ethinylestradiol Jenapharm
Ethinylestradiol [INN:BAN:JAN]
Ethinylestradiolum
Ethinylestradiolum [INN-Latin]
Ethinylestriol
Ethinyloestradiol
Ethinyloestradiol [Steroidal oestrogens]
Ethy 11
Ethynyl estradiol
Ethynylestradiol
Ethynylestradiol, Ethinyl Estradiol
Ethynyloestradiol
Eticyclin
Eticyclol
Eticylol
Etinestrol
Etinestryl
Etinilestradiol
Etinilestradiol [INN-Spanish]
Etinilestradiolo
Etinilestradiolo [DCIT]
Etinoestryl
Etistradiol
Etivex
Evra
Feminone
Fempatch
Follicoral
Ginestrene
Gynodiol
Gynolett
HMS2051I19
HSDB 3587
Halodrin
Hemihydrate, Ethinyl Estradiol
Inestra
Innofem
Jenapharm Brand of Ethinyl Estradiol
Jenapharm, Ethinylestradiol
Kolpolyn
LMST02010036
LS-231
Linoral
Lynoral
MLS000028479
MLS000758274
Marvelon
Menolyn
Menostar
Mercilon
Microfollin
Microfollin Forte
MolPort-001-794-636
NCGC00091533-01
NCGC00091533-04
NCGC00091533-05
NCI60_000234
NSC-10973
NSC10973
Neo-Estrone
Nogest-S
Novestrol
OVULEN-21
OVULEN-28
Oradiol
Orestralyn
Orestrayln
Organon Brand of Ethinyl Estradiol
Ortho-Cyclen
Ovex
Oviol
PUBERTAL ETHINYL ESTRADIOL STUDY
Palonyl
Perovex
Primogyn
Primogyn C
Primogyn M
Progynon C
Progynon M
Prosexol
S1625_Selleck
SAM001247008
SGCUT00127
SMR000058319
Schering Brand of Ethinyl Estradiol
Spanestrin
Thiuram E
Thiuranide
UNII-423D2T571U
Vagifem
Varnoline
WLN: L E5 B666TTT&J E1 FQ F1UU1 OQ
Ylestrol
component of Demulen
component of Oracon
component of Ortrel
ethinyl estradiol
ethynyl estradiol
to_000048
7
MethadoneapprovedPhase 4, Phase 130576-99-34095
Synonyms:
(+)-Methadone
(+-)-Methadone
(+/-)-Methadone
(+/-)-Methadone hydrochloride
(+/-)-Tussal
(-)-(R)-6-(Dimethylamino)-4,4-diphenyl-3-heptanone
(-)-Methadone
(6R)-Methadone
(R)-6-(Dimethylamino)-4,4-diphenyl-3-heptanone
(R)-6-(Dimethylamino)-4,4-diphenyl-3-hetpanone
(S)-6-(Dimethylamino)-4,4-diphenyl-3-heptanone
(±)-methadone
1095-90-5 (hydrochloride)
297-88-1
3-14-00-00278 (Beilstein Handbook Reference)
3-14-00-00279 (Beilstein Handbook Reference)
3-Hetpanone, 6-(dimethylamino)-4,4-diphenyl-, (R)- (9CI)
5653-80-5
6-(Dimethylamino)-4,4-diphenyl-3-heptanone dl-mixture
6-(dimethylamino)-4,4-diphenylheptan-3-one
6-Dimethylamino-4,4-diphenyl-3-heptanone
6-dimethylamino-4,4-di(phenyl)heptan-3-one
6S-Methadone
76-99-3
A 4624
AC-16055
AC1L1HEG
AC1Q2RLW
AN 148
AN-148 (*Hydrochloride*)
Adanon
Adanon hydrochloride
Adolan
Algidon
Algolysin
Algovetin
Althose
Althose hydrochloride
Amidon
Amidone
BRN 3213667
BRN 3213668
BRN 3213669
Biscuits
Butalgin
C07163
CHEBI:6807
CHEMBL651
CID4095
D08195
DB00333
DEA No. 9250
DL-Methadone hydrochloride
Depridol
Dextromethadone
Diaminon
Diaminon hydrochloride
Diskets
DivK1c_000963
Dl-Methadone
Dollies
Dolly
Dolofin hydrochloride
Dolohepton
Dolophin
Dolophin hydrochloride
Dolophine
Dolophine (*Hydrochloride*)
Dolophine HCL
EINECS 200-996-9
Fenadon
Fenadone
 
Fenadone (*Hydrochloride*)
HSDB 3119
Heptadon
Heptadone
Heptadone (*Hydrochloride*)
Heptanon
Heptanon (*Hydrochloride*)
Heptanon (pharmaceutical)
Hoechst 10820
Hoescht 10820 (*Hydrochloride*)
IDI1_000963
K 174
KBio1_000963
Ketalgin
Ketalgin hydrochloride
L-(+)-Methadone
L-6-(Dimethylamino)-4,4-diphenyl-3-heptanone
L-Polamidon
L000874
LS-74485
LS-74486
LS-74487
Levometadona
Levometadona [INN-Spanish]
Levomethadone [INN]
Levomethadonum
Levomethadonum [INN-Latin]
Levothyl
Mecodin
Mephenon
Metadona
Metadona [INN-Spanish]
Metadona [Spanish]
Metadone
Metadone [DCIT]
Metasedin
Methadon
Methadona
Methadona [Spanish]
Methadone (BAN)
Methadone HCL
Methadone HCL Intensol
Methadone Hydrochloride
Methadone M
Methadone [INN:BAN]
Methadone hydrochloride
Methadonum
Methadonum [INN-Latin]
Methadonum [Latin]
Methadose
Methaquaione
Miadone
Moheptan
MolPort-001-785-650
NINDS_000963
Phenadone
Phenadone (*Hydrochloride*)
Phenadone hydrochloride
Physeptone
Polamidon
Polamidone
Polamivet
Racemic methadone
S-(+)-Methadone
Sedo-Rapide
Tussol
UNII-UC6VBE7V1Z
Westadone
d-6-(Dimethylamino)-4,4-diphenyl-3-heptanone
d-Methadone
dl-Methadone
l-Methadone
l-Polamivet
methadone
8
ProgesteroneapprovedPhase 4, Phase 250057-83-05994
Synonyms:
(S)-4-Pregnene-3,20-dione
(S)-Pregn-4-en-3,20-dione
(S)-Progesterone
.beta.-Progesterone
.delta.(sup4)-Pregnene-3,20-dione
.delta.4-Pregnene-3,20-dione
17.alpha.-Progesterone
17a-Progesterone
17alpha-Progesterone
17alpha-progesterone
17α-progesterone
1dbb
1h60
257630-50-5
3,20-Pregnene-4
32104FB6-BF81-4F6E-83C2-024DEEAEB272
4-Pregnen-3,20-dione
4-Pregnene-3,20-dione
46665_FLUKA
46665_RIEDEL
57-83-0
753497-20-0
8012-32-6
8023-13-0
AC-700
AC1L1LKF
AI3-51682
Agolutin
Akrolutin
BB_NC-0185
BHR-100
BIDD:ER0547
BIDD:PXR0094
BPBio1_000676
BRD-K64994968-001-03-6
BSPBio_000614
Bio-luton
C00410
CCRIS 533
CHEBI:17026
CHEMBL103
CID5994
CIDR
CMC_13406
COL-1620
CPD000058345
Colprosterone
Corlutin
Corlutina
Corluvite
Corporin
Corpus Luteum Hormone
Corpus luteum hormone
Crinone
Crinone (TN)
Crinone progesterone gel
Curretab
Cyclogest
Cyclogesterin
D00066
D4-Pregnene-3,20-dione
DB00396
DR-2011
Delalutin
Delta(4)-pregnene-3,20-dione
Duraprogen
EINECS 200-350-6
ETI-411
EU-0100895
Endometrin
Estima
FE-999913
Flavolutan
Fologenon
Gelbkoerperhormon
Gesterol
Gesterol 100
Gesterol 50
Gestiron
Gestone
Gestormone
Gestron
Glanducorpin
Gynlutin
Gynoluton
Gynolutone
HMS1569O16
HMS2051O05
HMS2090J07
HSDB 3389
Hormoflaveine
Hormoluton
Hydroxyprogesterone Caproate
Hydroxyprogesterone Caproic acid
LMST02030159
LS-234
Lingusorbs
Lipo-Lutin
Lipolutin
Lopac0_000895
Lucorteum
Lucorteum Sol
Lucorteum sol
Lugesteron
Luteal hormone
Luteinique
Luteocrin normale
Luteodyn
Luteogan
Luteohormone
Luteol
Luteol (VAN)
Luteopur
Luteosan
Luteostab
Luteovis
Luteum
Lutex
Lutidon
Lutin
Lutinus
Lutociclina
Lutocuclin M
Lutocyclin
Lutocyclin M
 
Lutocyclin m
Lutocylin
Lutocylol
Lutoform
Lutogyl
Lutogynon
Lutren
Lutromone
MLS000028517
MLS000758277
MLS001074187
MLS002222367
MPA
Membrettes
Methylpregnone
Micronized Progesterone
MolPort-001-794-643
NCGC00022185-03
NCGC00022185-04
NCGC00022185-05
NCGC00022185-06
NCGC00022185-07
NCGC00022185-08
NCGC00022185-09
NCGC00090798-01
NCGC00090798-02
NCI60_042166
NSC 64377
NSC 9704
NSC-9704
NSC64377
NSC9704
Nalutron
Natural Progesterone
P 0130
P0130_SIGMA
P0478
P3972_SIGMA
P6149_SIGMA
P7556_ALDRICH
P7556_SIGMA
P8783_SIGMA
P9776_SIGMA
PROGESTERONE
Percutacrine
Percutacrine Luteinique
Piaponon
Pranone
Pregn-4-en-3,20-dione
Pregn-4-ene-3,20-dione
Pregnene-3,20-dione
Pregnenedione
Prestwick0_000477
Prestwick1_000477
Prestwick2_000477
Prestwick3_000477
Prestwick_411
Primolut
Prochieve
Progeffik
Progekan
Progestan
Progestasert
Progesterol
Progesteron
Progesterona
Progesterona [INN-Spanish]
Progesterone
Progesterone (JP15/USP/INN)
Progesterone [INN:BAN:JAN]
Progesterone [Progestins]
Progesterone, water-soluble
Progesterone-Water Soluble
Progesterone: HBC complex
Progesteronum
Progesteronum [INN-Latin]
Progestin
Progestogel
Progestol
Progeston
Progestone
Progestosol
Progestrel
Progestron
Progestronol
Progestérone
Projestaject
Prolets
Prolidon
Prolutin
Proluton
Prolutone
Prometrium
Prometrium (TN)
Prontogest
Protormone
S00293
S1705_Selleck
SAM001247039
SMR000058345
SMR000653542
SPBio_002553
SR-01000000088
SR-01000000088-5
Spectrum5_002053
Syngesterone
Syngestrets
Synovex S
Syntolutan
U 3672
UNII-4G7DS2Q64Y
Utrogest
Utrogestan
Vitarrine
WLN: L E5 B666 OV MUTJ A1 E1 FV1
ZINC04428529
beta-Progesterone
bmse000482
component of Cyclogesterin
corpus luteum hormone
delta(4)-Pregnene-3,20-dione
delta(Sup 4)-Pregnene-3,20-dione
delta(Sup4)-pregnene-3,20-dione
delta(sup 4)-Pregnene-3,20-dione
delta4-Pregnene-3,20-dione
luteohormone
nchembio.2007.53-comp14
9
GuaifenesinapprovedPhase 4, Phase 151293-14-13516
Synonyms:
3-(2-Methoxyphenoxy)-1,2-propanediol
3-(O-Methoxyphenoxy)-1,2-propanediol
3-(O-Methoxyphenoxy)-propanediol-1,2
3-O-Methoxyphenoxypropane 1:2-diol
7 Select Mucus Relief
Actifed C
Adult Tussin
Adult Tussin chest congestion
Aeronesin
Air Power
Amonidren
Amonidrin
Aresol
Benylin-E
Bidex-400
Bronchol
Broncomar SF
Careone Adult Tussin
Careone Mucus Er
Careone Mucus Relief childrens
Chest Congestion
Chest Congestion Relief
Chest Congestion childrens
Childrens Chest Congestion
Childrens Chest Congestion Relief
Childrens Mucinex Chest Congestion
Childrens Mucinex Mini-Melts Chest Congestion
Childrens Mucus Relief
Childrens Mucus Relief Expectorant Grape
Childrensrelief Expectorant Grape
Cough
Cough Out
Dg Health Mucus Relief Er
Diabetic Siltussin Das-na
Diabetic Tussin Expectorant
Diabetic Tussin Mucus Relief
Equaline Mucus Er
Equaline Tussin chest congestion
Equate Mucus Er
Equate Tussin Adult Chest Congestion
Expectorant
Expectorant 12 Hour
Gadavyt Cough
Geri-tussin Expectorant
Glycerin ether
Glycerin guaiacolate
Glycero-guaiacol ether
Glycerol a-(2-methoxyphenyl) ether
Glycerol a-(O-methoxyphenyl)ether
Glycerol a-guaiacyl ether
Glycerol a-guiacyl ether
Glycerol a-monoguaiacol ether
Glycerol guaiacolate
Glycerol mono(2-methoxyphenyl) ether
Glycerol-a-guajakolether
Glycerol-alpha-guajakolether
Glyceryl guaiacol
Glyceryl guaiacol ether
Glyceryl guaiacolate
Glyceryl guaiacolate ether
Glyceryl guaiacyl ether
Glyceryl guaicolate
Glyceryl guiacolate
Glycerylguaiacol
Good Neighbor Pharmacy Mucus Er
Good Neighbor Pharmacy Mucus Relief
Good Neighbor Pharmacy Tabtussin
Good Neighbor Pharmacy Tussin
Good Sense Mucus Er
Good Sense Mucus Relief
Good Sense Tussin chest congestion
Guaap
Guaiacol glycerol ether
Guaiacol glyceryl ether
Guaiacolglicerinetere
Guaiacuran
Guaiacurane
Guaiacyl glyceryl ether
Guaiamar
Guaianesin
Guaicol glycerine ether
Guaicol glyceryl ether
Guaifenesin
Guaifenesin Extended Release
Guaifenesine
Guaiphenesin
Guaiphenesine
Guaiphesin
Guiatuss
Health Mart Adult Tussin
Health Mart Mucus Er
Healthmart Chest Congestion Relief
Healthy Accents Childrens Mucus Relief
Healthy Accents Mucus Relief
Healthy Accents Tussin
Healthy Accents Tussin Chest Congestion adult
Hustosil
 
Iophen Nr
Kids-eeze Chest Relief
Leader Adult Tussin Chest Congestion
Leader Adult Tussin Mucus Plus Chest Congestion
Leader Chest Congestion Relief G450
Leader Cough Tabs
Leader Mucus Er
Leader Mucus Relief childrens
Leader Tabtussin 400
Licorice Coughing Liquid
Liqufruta
Liquituss Gg
Little Remedies Little Colds Mucus Relief Expectorant Melt Aways
Methoxypropanediol
Methphenoxydiol
Metossipropandiolo
Mucaplex
Mucinex
Mucinex For Kids
Mucinex Maximum Strength
Mucinex for Kids
Mucosa
Mucus Er
Mucus Extended Release
Mucus Releif Expectorant
Mucus Relief
Mucus Relief Chest
Mucus Relief Er
Mucus Relief Expectorant
Mucus Relief Immediate Release
O-Methoxyphenyl glyceryl ether
Organ-i Nr
Organidin NR
Pancold S
Pneumomist
Preferred Plus Chest Congestion Relief
Preferred Plus Mucus Er
Preferred Plus Tabtussin
Premier Value Chest Congestion Relief
Propanosedyl
Q-tussin
Qtussin
Quality Choice Mucus Relief
Reduton
Refenesen
Refenesen Chest Congestion Relief
Respaire-30
Ritussin Expectorant
Robafen Cough Formula
Robitussin
Robitussin Mucus Plus Chest Congestion
Rompe Pecho
Rompe Pecho EX
Rompe Pecho SF
Rugby Mucus Er
Rx Act Tussin Chest Congestion
Scot-tussin Expectorant Sf Cough
Select Brand Coughtab 400
Select Brand Mucus Relief
Select Brand Tab Tussin
Selecthealth Tussin Dm
Shopko Chest Congestion Relief
Shoprite Adult Tussin
Shoprite Mucus Relief
Siltussin Das
Siltussin Sa
Simpex Guaifenesin
Simply Right Mucus Relief
Smart Sense Childrens Mucus Relief
Smart Sense Mucus Er
Smart Sense Tussin adult
Sunmark Mucus Er
Sunmark Tussin
Sunmark Tussin chest congestion
The Medicine Shoppe Chest Congestion Relief
Topcare Mucus Er
Topcare Mucus Relief
Topcare Tussin Chest Congestion
Topcare Tussin mucus plus chest congestion
Tussin
Tussin Adult chest congestion
Tussin Chest
Tussin Chest Congestion Adult Non Drowsy
Tussin Chest Congestion Non Drowsy
Tussin EXPECTORANT
Tussin Non Drowsy
Tussin Original
Tussin adult chest congestion
Tussin adults non drowsy
Tussin expectorant for adults
Tussin mucus plus chest congestion
Ultra Tuss
Wal Tussin adult chest congestion
a-Glyceryl guaiacol ether
a-Glyceryl guaiacolate ether
alpha-Glyceryl guaiacol ether
alpha-Glyceryl guaiacolate ether
guaiphenesin
p-Cresyl acetate
10
Aripiprazoleapproved, investigationalPhase 4, Phase 2342129722-12-960795
Synonyms:
129722-12-9
24-29-3
7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydro-2(1H)-quinolinone
7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydrocarbostyril
7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butyloxy)-3,4-dihydro-2(1H)-quinolinone
7-[4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydrocarbostyril
7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one
7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}-3,4-dihydroquinolin-2(1H)-one
AC-1554
AC1L1TXZ
AC1Q3T38
ALKS-9070
Abilify
Abilify (TN)
Abilify DISCMELT
Abilify Discmelt
Abilify Maintena
Abilitat
Aripiprazol
Aripiprazole
Aripiprazole (JAN/USAN/INN)
Aripiprazole [USAN]
Aripiprazolum
Aripirazole
Arpizol
Asprito|
BMS-337039
Bio-0004
Bristol-Myers Squibb brand of aripiprazole
C094645
C12564
C23H27Cl2N3O2
CHEBI:31236
CHEMBL1112
CID60795
 
CPD000466383
D01164
DB01238
Discmelt
FT-0082572
HMS2051I18
HMS2089M20
HMS2093F22
HSDB 7320
KS-1030
L001339
LS-142666
MLS000759517
MLS001165779
MLS001195621
MLS001424078
MolPort-002-885-808
MolPort-003-844-657
NCGC00159510-02
NCGC00159510-03
OPC 31
OPC-14597
OPC-31
Opc 14597
Otsuka brand of aripiprazole
Pripiprazole
S06-0010
SAM001246750
SMR000466383
STK625160
TL8000707
TL80090184
UNII-82VFR53I78
aripiprazol
aripiprazole
aripiprazolum
||OPC 14597
11
Testosteroneapproved, investigationalPhase 447458-22-06013
Synonyms:
(+)-testosterone
(+-)-8-iso-testosterone
(+-)-retrotestosterone
(+-)-testosterone
(17b)-17-hydroxy-androst-4-en-3-one
(17beta)-17-Hydroxyandrost-4-en-3-one
(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
13-Iso-testosterone
17-Hydroxy-(17-beta)-androst-4-en-3-one
17-Hydroxy-(17beta)-androst-4-en-3-one
17-Hydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-3-one
17-Hydroxy-D4-androsten-3-one
17-Hydroxy-androst-4-en-3-one
17-beta-Hydroxy-delta(sup 4)-androsten-3-one
17-beta-Hydroxyandrost-4-en-3-one
17?-Hydroxy-4-androsten-3-one
17a-Hydroxy-(13a)-androst-4-en-3-one
17a-Hydroxy-13a-androst-4-en-3-one
17a-Hydroxy-14b-androst-4-en-3-one
17a-Hydroxy-androst-4-en-3-one
17b-Hydroxy-(10a)-androst-4-en-3-one
17b-Hydroxy-(13a)-androst-4-en-3-one
17b-Hydroxy-(8a)-androst-4-en-3-one
17b-Hydroxy-(8a,10a)-androst-4-en-3-one
17b-Hydroxy-(9b)-androst-4-en-3-one
17b-Hydroxy-(9b,10a)-androst-4-en-3-one
17b-Hydroxy-13a-androst-4-en-3-one
17b-Hydroxy-8a-androst-4-en-3-one
17b-Hydroxy-D4-androsten-3-one
17b-Hydroxy-androst-4-en-3-on
17b-Hydroxy-androst-4-en-3-one
17b-Hydroxyandrost-4-en-3-one
17b-Hydroxyandrost-4-ene-3-one
17b-Testosterone
17b-hydroxy-4-androsten-3-one
17beta-Hydroxy-3-oxo-4-androstene
17beta-Hydroxy-4-androsten-3-one
17beta-Hydroxy-delta(sup4)-androsten-3-one
17beta-Hydroxyandrost-4-en-3-one
17beta-Hydroxyandrost-4-ene-3-one
17beta-hydroxy-4-androsten-3-one
4-Androsten-17?-ol-3-one
4-Androsten-17beta-ol-3-one
4-Androsten-3-one-17b-ol
4-androsten-17β-ol-3-one
4-androstene-17beta-ol-3-one
46923_FLUKA
46923_RIEDEL
58-22-0
7-beta-Hydroxyandrost-4-en-3-one
8-Iso-testosterone
9b,10a-Testosterone
9b-Testosterone
AA 2500
AC-14899
AC1L1LM0
Andriol
Andro
Andro 100
Andro L.A. 200
AndroGel
Androderm
Androderm (TN)
Androgel
Androgel (TN)
Android 10
Android 25
Android 5
Androlin
Andronaq
Andronate 100
Andronate 200
Andropatch
Andropository 200
Androsorb
Androst-4-en-17b-ol-3-one
Androst-4-en-17beta-ol-3-one
Androst-4-ene-17b-ol-3-one
Andrusol
Andryl 200
Aveed
Axiron
B5DEE83F-632B-48A1-A0ED-A51E7F13DF2E
BIDD:ER0555
BIM-0061761.0001
Beta Testosterone
Bio-0678
Bio-T-Gel
C00535
CCRIS 574
CDB 111C
CHEBI:17347
CHEMBL386630
CID6013
CMC_13449
COL 1621
CP 601B
CPD000058344
Cristerona T
Cristerone T
D00075
D4-Androsten-17b-ol-3-one
DB00624
Dea No. 4000
Delatest
Delatestryl
Depo-Testadiol
Depo-Testosterone
Depo-Testosterone Cypionate
Depo-testosterone
Depotest
EINECS 200-370-5
Epitestosteron
Everone 200
Fortesta
Geno-Cristaux Gremy
Geno-cristaux Gremy
Geno-cristaux gremy
HMS2052N11
HSDB 3398
Halotensin
Homosteron
Homosterone
Intrinsa
 
LMST02020002
LS-148813
LibiGel
Libigel
Lumitestosteron
MLS000563091
MLS001032098
MLS001306401
MLS002174283
Malerone
Malestrone
Malestrone (amps)
Malogen in Oil
Malogen, Aquaspension Injection
Malogen, aquaspension injection
Mertestate
Metandren
Methyltestosterone
MolPort-002-506-901
NCGC00091018-01
NSC 9700
Natesto nasal gel
Neo-Hombreol F
Neo-Testis
Neo-testis
Neotestis
Oreton
Oreton F
Oreton Methyl
Oreton-F
Orquisteron
Perandren
Percutacrine Androgenique
Percutacrine androgenique
Primotest
Primoteston
Rac-17b-hydroxy-(13a)androst-4-en-3-one
Rac-17b-hydroxy-(8a)-androst-4-en-3-one
Rac-17b-hydroxy-(9b,10a)androst-4-en-3-one
Rac-17b-hydroxy-androst-4-en-3-one
Relibra
Retrotestosterone
S00309
S2033_Selleck
SAM001246921
SMR000058344
SMR001261453
Scheinpharm Testone-Cyp
Striant
Striant (TN)
Sustanon
Sustanone
Sustason 250
Synandrol F
T-Cypionate
T1500_SIGMA
T5411_FLUKA
T5411_SIGMA
TES
Teslen
Testamone 100
Testandrone
Testaqua
Testiculosterone
Testim
Testim (TN)
Testobase
Testoderm
Testoderm Tts
Testogel
Testoject-50
Testolent
Testolin
Testopel
Testopel Pellets
Testopropon
Testosteroid
Testosteron
Testosterona
Testosterona [INN-Spanish]
Testosterone
Testosterone (JAN/USP)
Testosterone Cypionate
Testosterone Enanthate
Testosterone Gel
Testosterone Heptanoate
Testosterone Hydrate
Testosterone Propionate
Testosterone Undecanoate
Testosterone [Androgenic steroids, anabolic]
Testosterone [INN:BAN]
Testosterone and its esters
Testosterone hydrate
Testosterone solution
Testosteronum
Testosteronum [INN-Latin]
Testostosterone
Testostérone
Testoviron
Testoviron Schering
Testoviron T
Testoxyl
Testred
Testred Cypionate 200
Testrin-P.A
Testro AQ
Testro Aq
Testrone
Testryl
Tostrelle
Tostrex
Trans-Testosterone
UNII-3XMK78S47O
Viatrel
Virilon
Virilon IM
Virormone
Virosterone
Vogelxo
ZINC06500184
beta testosterone
delta(sup 4)-Androsten-17(beta)-ol-3-one
delta4-Androsten-17beta-ol-3-one
delta4-androsten-17b-ol-3-one
testosterone
trans-Testosterone
12
MethyltestosteroneapprovedPhase 447458-18-46010
Synonyms:
17(alpha)-Methyl-delta(4)-androsten-17(beta)-ol-3-one
17-Methyltestosterone
17-beta-Hydroxy-17-methylandrost-4-en-3-one
17-methyltestosterone
17alpha-Methyl-3-oxo-4-androsten-17beta-ol
17alpha-Methyl-delta(4)-androsten-17beta-ol-3-one
17alpha-Methyltestosterone
17alpha-methyl-delta-androsten-17beta-ol-3-one
17alpha-methyltestosterone
17beta-Hydroxy-17-methylandrost-4-en-3-one
 
17α-methyl-Δ4-androsten-17β-ol-3-one
17α-methyltestosterone
4-Androstene-17alpha-methyl-17beta-ol-3-one
Android
Methitest
Methyltestosterone
Methyltestosteronum
Metiltestosterona
NSC-9701
Testred
Testred C-III
Virilon
13
RifampicinapprovedPhase 430313292-46-15458213, 5381226
Synonyms:
1-b]furan-21-yl acetate
13292-46-1
3-(((4-Methyl-1-piperazinyl)imino)-methyl)rifamycin
3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV
3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin sv
3-(4-Methylpiperazinyliminomethyl)-rifamycin SV
3-(4-Methylpiperazinyliminomethyl)rifamycin SV
3-([(4-Methyl-1-piperazinyl)imino]methyl)rifamycin SV
3-[(4-Methyl-1-piperazinyl)iminomethyl]rifamycin SV
3-[[(4-Methyl-1-piperazinyl)imino]-methyl]rifamycin
46713_FLUKA
46713_RIEDEL
62534-43-4
8-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV
8-(4-Methylpiperazinyliminomethyl) rifamycin SV
8-[[(4-Methyl-1-piperazinyl)imino[methyl]rifamycin
8-[[(4-Methyl-1-piperazinyl)imino]methyl]rifamycin sv
8-[[(4-Methylpiperazinyl)imino]methyl]rifamycin sv
83907_FLUKA
83907_SIGMA
8CI)
AZT + Rifampin
Abrifam
Archidyn
Arficin
Arzide
BA-41166E
BIDD:PXR0014
BPBio1_000561
BSPBio_000509
Ba 41166
Ba 41166/E
Benemicin
Benemycin
Bio-0621
C06688
C43H58N4O12
CAS-13292-46-1
CCRIS 551
CHEBI:28077
CHEBI:455936
CHEMBL180
CID5381226
CID5388984
CID5458213
CID5702112
CID6604339
CID6708473
CID6842115
CID6912767
CID6913622
CPD001906767
D00211
DB01045
DRG-0109
Dione 21-acetate
Dipicin
DivK1c_000550
Doloresum
EINECS 236-312-0
Eremfat
Famcin
Fenampicin
HMS1569J11
HMS1920P08
HMS2089F12
HMS2092G09
HMS501L12
HSDB 3181
KBio1_000550
KBio2_000919
KBio2_003487
KBio2_006055
KBio3_003018
KBioGR_001780
KBioSS_000919
L-5103
L-5103 Lepetit
LS-7689
MLS000028552
MLS001148237
MLS001333745
MolPort-000-767-051
MolPort-002-513-586
MolPort-003-666-281
MolPort-006-395-891
NCGC00016699-01
NCGC00017365-01
NCGC00018178-01
NCGC00022678-03
NCGC00022678-04
NCGC00022678-05
NCGC00160500-01
 
NCI60_000309
NINDS_000550
NSC 113926
NSC-113926
NSC113926
Piperine & Rifampicin
Prestwick0_000525
Prestwick1_000525
Prestwick2_000525
Prestwick3_000525
Prestwick_833
R-Cin
R/AMP
R0079
R3501_SIAL
R3501_SIGMA
R5777_SIGMA
R7382_SIGMA
RAMP
RFP
RMP
Ramp
Reserpine & Rifampicin
Rf
Rfamipicin
Rifa
Rifadin
Rifadin (TN)
Rifadin I.V
Rifadin I.V.
Rifadin IV
Rifadin Iv
Rifadin, Rimactane, Rifampicin, Rifampin
Rifadine
Rifagen
Rifaldazin
Rifaldazine
Rifaldin
Rifam
Rifamicin AMP
Rifamor
Rifampicin
Rifampicin & EEP
Rifampicin & Propolis
Rifampicin (JP15/INN)
Rifampicin SV
Rifampicin [INN:BAN:JAN]
Rifampicin sodium
Rifampicina
Rifampicina [INN-Spanish]
Rifampicine
Rifampicine [French]
Rifampicinum
Rifampicinum [INN-Latin]
Rifampin
Rifampin (USP)
Rifampin [USAN]
Rifamsolin
Rifamycin
Rifamycin AMP
Rifamycin Amp
Rifaprodin
Rifcin
Rifinah
Rifobac
Rifoldin
Rifoldine
Riforal
Rimactan
Rimactane
Rimactane (TN)
Rimactazid
Rimactin
Rimactizid
Rimazid
Rimycin
Rofact
S1764_Selleck
SAM002264646
SMR000058322
SMR000653525
SPBio_002430
SPECTRUM1500529
STK080143
Sinerdol
Spectrum3_001837
Spectrum4_001250
Spectrum5_002018
Spectrum_000439
TNP00313
Tubocin
UNII-VJT6J7R4TR
WLN: V1 WQ A&1 E&1 E1UN- AT6N DNTJ D1
nchembio884-comp4
rifampin
14Antitussive AgentsPhase 4, Phase 1425
15NarcoticsPhase 4, Phase 12709
16Chlorpheniramine, phenylpropanolamine drug combinationPhase 4, Phase 1512
17Peripheral Nervous System AgentsPhase 4, Phase 2, Phase 118510
18HormonesPhase 4, Phase 211748
19FluoroquinolonesPhase 4, Phase 1242
20Nucleic Acid Synthesis InhibitorsPhase 4, Phase 13836
21AnticonvulsantsPhase 4, Phase 12249
22ProgestinsPhase 4, Phase 2433
23Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 4, Phase 29988
24Anti-Arrhythmia AgentsPhase 4, Phase 3, Phase 2, Phase 12371
25Hormone AntagonistsPhase 4, Phase 210002
26AnalgesicsPhase 4, Phase 19358
27Respiratory System AgentsPhase 4, Phase 13931
28Analgesics, OpioidPhase 4, Phase 12304
29Psychotropic DrugsPhase 4, Phase 2, Phase 15501
30Tranquilizing AgentsPhase 4, Phase 2, Phase 13597
31Anti-Bacterial AgentsPhase 4, Phase 2, Phase 3, Phase 19140
32Contraceptive AgentsPhase 4, Phase 2, Phase 3, Phase 11706
33Neurotransmitter AgentsPhase 4, Phase 2, Phase 114795
34Lithium CarbonatePhase 4211
35Antidepressive AgentsPhase 42367
36Antimanic AgentsPhase 4663
37Antipsychotic AgentsPhase 4, Phase 2, Phase 12130
38Central Nervous System DepressantsPhase 4, Phase 2, Phase 110016
39Contraceptives, OralPhase 4, Phase 2, Phase 3, Phase 13734
40Anti-Infective AgentsPhase 4, Phase 2, Phase 3, Phase 117220
41Estradiol 3-benzoatePhase 4, Phase 2, Phase 3, Phase 11094
42Estradiol valeratePhase 4, Phase 2, Phase 3, Phase 11094979-32-8
43Norgestimate, ethinyl estradiol drug combinationPhase 4, Phase 2, Phase 3, Phase 1409
44Polyestradiol phosphatePhase 4, Phase 2, Phase 3, Phase 11095
45Estradiol 17 beta-cypionatePhase 4, Phase 2, Phase 3, Phase 11094
46Topoisomerase InhibitorsPhase 4, Phase 2, Phase 3, Phase 14081
47Contraceptives, Oral, CombinedPhase 4, Phase 2, Phase 3, Phase 1566
48
CorticosteronePhase 4950-22-65753
Synonyms:
11,21-Dihydroxypregn-4-ene-3,20-dione
11,21-Dihydroxyprogesterone
11-Hydroxycorticoaldosterone
 
17-Deoxycortisol
4-Pregnene-11 Corticosteron
Corticosterone
Kendall'S compound B
Reichstein'S substance H
49Fluorodeoxyglucose F18Phase 4356
50Testosterone undecanoatePhase 4474

Interventional clinical trials:

(show top 50)    (show all 78)
idNameStatusNCT IDPhase
1A Study of Aripiprazole (Abilify) in Patients With Bipolar ManiaCompletedNCT00261443Phase 4
2Genetics of QT Response to MoxifloxacinEnrolling by invitationNCT01936480Phase 4
3Imaging of Brain Amyloid Plaques in the Aging PopulationEnrolling by invitationNCT00950430Phase 4
4Adjunct Methadone to Decrease the Duration of Mechanical Ventilation in the Medical Intensive Care UnitEnrolling by invitationNCT02025855Phase 4
5Influence of Testosterone Administration on Drug-Induced QT Interval Prolongation and Torsades de PointesNot yet recruitingNCT02513940Phase 4
6Pediatric Lead Extractability and Survival Evaluation (PLEASE)TerminatedNCT00335036Phase 4
7Pharmacokinetics and Safety of MoxifloxacinTerminatedNCT01329250Phase 4
8Effect of Eleclazine on Shortening of the QT Interval, Safety, and Tolerability in Adults With Long QT Syndrome Type 3RecruitingNCT02300558Phase 3
9Registry of Unexplained Cardiac ArrestRecruitingNCT00292032Phase 3
10Cardiac Sympathetic Denervation Surgery for Prevention of Ventricular TacharrhythmiasNot yet recruitingNCT01013714Phase 3
11Pragmatic Clinical Trial for a More Effective Concise and Less Toxic MDR-TB Treatment Regimen(s)Not yet recruitingNCT02589782Phase 2, Phase 3
12Influence of Progesterone Administration on Drug-Induced QT Interval LengtheningCompletedNCT01929083Phase 2
13A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic PatientsCompletedNCT00845026Phase 2
14Long QT Syndrome Screening in NewbornsRecruitingNCT02412709Phase 2
15Long Term Prophylactic Therapy of Congenital Long QT Syndrome Type III (LQT3) With RanolazineRecruitingNCT01728025Phase 2
16Efficacy Study of Sodium Channel Blocker in LQT3 PatientsRecruitingNCT01648205Phase 2
17Comparison of Two Macrolides, Azithromycin and Erythromycin, for Symptomatic Treatment of GastroparesisTerminatedNCT01323582Phase 2
18Effect of Oral GS-6615 on Dofetilide-Induced QT Prolongation, Safety, and Tolerability in Healthy AdultsCompletedNCT02365532Phase 1
19Study of the Effect of GS-6615 in Subjects With LQT-3CompletedNCT01849003Phase 1
20Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Renal FunctionCompletedNCT02441829Phase 1
21Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Hepatic FunctionCompletedNCT02412098Phase 1
22Study Evaluating the Effects of Multiple Oral Doses of ERB-041 on Cardiac Repolarization in Healthy SubjectsCompletedNCT00316459Phase 1
23Genetic Sources of Variability of the Adaptation of the Ventricular RepolarisationCompletedNCT00773201Phase 1
24Evaluation of Possible Effects on the QT/ QTc Interval of Rupatadine in Healthy VolunteersCompletedNCT00199225Phase 1
25Ability of Late Sodium or Calcium Current Block to Balance the ECG Effects of Potassium Current BlockCompletedNCT02308748Phase 1
26To Investigate the Effect of Intravenous Ondansetron on Cardiac Conduction as Compared to Placebo and Moxifloxacin in Healthy Adult SubjectsCompletedNCT01449188Phase 1
27A Dose Ranging Escalation Study of Tramadol Hydrochloride in Healthy VolunteersCompletedNCT01947920Phase 1
28Food and Insulin Effect on QT/QTC Interval of ECGCompletedNCT01642485Phase 1
29Selections of Subjects With Important Changes in Their Cardiac Repolarization Parameters for the Procurement of Skin and Blood SamplesCompletedNCT01338441Phase 1
30Study To Evaluate The Effect Of A Multiple Oral Dose Of PF-00232798 On QT Intervals In Healthy SubjectsCompletedNCT01140425Phase 1
31QT/QTc Study of 2 Doses of ADASUVE®CompletedNCT01854710Phase 1
32A Phase 1 Study to Evaluate Effects of Sapropterin Dihydrochloride on QTc Intervals in Healthy Adult SubjectsCompletedNCT00789568Phase 1
33Safety and Pharmacokinetics of Quinidine Alone and in Combination With Dabigatran EtexilateCompletedNCT02171624Phase 1
34Race Difference Moxifloxacin-induced QT Prolongation Between Healthy Chinese and Caucasian VolunteersRecruitingNCT02119091Phase 1
35A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor ReceptorRecruitingNCT02365662Phase 1
36Effect of Eleclazine on QT, Safety, and Tolerability in Adults With Long QT2 SyndromeActive, not recruitingNCT02365506Phase 1
37Methadone Pharmacokinetics and Cardiac Effects in NewbornsActive, not recruitingNCT00715988Phase 1
38Effect of Potassium and Acetazolamide on People With Andersen-Tawil SyndromeTerminatedNCT00839501Phase 1
39The Long QT Syndrome in PregnancyCompletedNCT00488254
40Long QT Syndrome-Population Genetics and Cardiac StudiesCompletedNCT00005176
41ECG Signal Collection From Long QT Syndrome, Wide QRS Complexes, Heart Failure, and Cardiac Resynchronization PatientsCompletedNCT00399412
42Linkage Study of Long QT Syndrome In An Amish KindredCompletedNCT00005250
43QT-prolongation in Psychiatric HospitalsCompletedNCT02043925
44Drug Interactions With Risk of QT-prolongation in a General HospitalCompletedNCT02043912
45Risk of QT-prolongation and Torsade de Pointes in Patients Treated With Acute Medication in a University HospitalCompletedNCT02068170
46Does Azithromycin Cause QT Prolongation in Hospitalized Patients With Severe Community Acquired Pneumonia?CompletedNCT01553734
47Effect of Beta-blocker Therapy on QTc Response in Exercise and Recovery in Normal SubjectsCompletedNCT00588965
48Epidemiology of Long QTand Asian Sudden Death in SleepCompletedNCT00005367
49The Effect of General Anesthesia on the Risk for ArrhythmiaCompletedNCT01174251
50Effects Rapid Atrial Pacing Has on the Electrocardiogram (ECG) in Patients With Dual Chamber PacemakersCompletedNCT00883610

Search NIH Clinical Center for Long Qt Syndrome


Cochrane evidence based reviews: long qt syndrome

Genetic Tests for Long Qt Syndrome

About this section

Genetic tests related to Long Qt Syndrome:

id Genetic test Affiliating Genes
1 Long Qt Syndrome22

Anatomical Context for Long Qt Syndrome

About this section

MalaCards organs/tissues related to Long Qt Syndrome:

33
Heart, Brain, Testes, Lung, Skin, Breast, Prostate

Animal Models for Long Qt Syndrome or affiliated genes

About this section

MGI Mouse Phenotypes related to Long Qt Syndrome:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053698.3CAV3, KCNH2, KCNJ2, KCNQ1, RYR2, SCN5A

Publications for Long Qt Syndrome

About this section

Articles related to Long Qt Syndrome:

(show top 50)    (show all 914)
idTitleAuthorsYear
1
Primary kidney parenchyma squamous cell carcinoma mimicking xanthogranulomatous pyelonephritis: A case report. (26998145)
2016
2
Intranasal surfactant protein D as neuroprotective rescue in a neonatal rat model of periventricular leukomalacia. (27109442)
2016
3
Poly(3,4-ethylenedioxythiophene) Nanoparticle and Poly(I/-caprolactone) Electrospun Scaffold Characterization for Skeletal Muscle Regeneration. (25855940)
2015
4
Anti-AI^ Autoantibodies in Amyloid Related Imaging Abnormalities (ARIA): Candidate Biomarker for Immunotherapy in Alzheimer's Disease and Cerebral Amyloid Angiopathy. (26441825)
2015
5
Clinicopathological correlation in asian patients with biopsy-proven lupus nephritis. (25874130)
2015
6
Comment on Sharma: platelet-rich-plasma injections for chronic planter fasciitis. (24384942)
2014
7
Monocyte subsets in atherosclerosis. (25396218)
2014
8
Influence of feeding practices on dental caries. A case-control study. (23597222)
2013
9
Inhibition of human high-affinity copper importer Ctr1 orthologous in the nervous system of Drosophila ameliorates AI^42-induced Alzheimer's disease-like symptoms. (23827522)
2013
10
SEMA3A deletion in a family with Kallmann syndrome validates the role of semaphorin 3A in human puberty and olfactory system development. (22416012)
2012
11
Giant Urinary Bladder and Bilateral Giant Hydronephrosis due to Bladder Neck Obstruction: One Case Report and Literature Review. (22606637)
2012
12
Wolfram Syndrome: a rare optic neuropathy in youth with type 1 diabetes. (21892113)
2011
13
Loss of E-cadherin in mouse gastric epithelial cells induces signet ring-like cells, a possible precursor lesion of diffuse gastric cancer. (21276134)
2011
14
Biosynthetic enzyme GMP synthetase cooperates with ubiquitin-specific protease 7 in transcriptional regulation of ecdysteroid target genes. (19995917)
2010
15
Muscle hypertrophy driven by myostatin blockade does not require stem/precursor-cell activity. (19383783)
2009
16
Tuberculous meningitis presenting with unusual clinical features in Nigerians: Two case reports. (18816394)
2008
17
Fibronectin binding and proteolytic degradation by Leishmania and effects on macrophage activation. (18212076)
2008
18
Motilin, ghrelin and related neuropeptides as targets for the treatment of GI diseases. (18342799)
2008
19
Malignant nephroblastoma in a common marmoset (Callithrix jacchus). (18192583)
2008
20
Ectopic ossification of the triceps muscle after application of bone morphogenetic protein-7 to the distal humerus for recalcitrant nonunion: a case report. (17482003)
2007
21
Protection against UV-light-induced skin carcinogenesis in SKH-1 high-risk mice by sulforaphane-containing broccoli sprout extracts. (16271437)
2006
22
Sinus histocytosis with massive lymphadenopathy (Rosai-Dorfman disease) in a patient with primary Sjogren's syndrome. (15163114)
2004
23
Necrotizing sialometaplasia: report of five cases. (15292869)
2004
24
Finding meaning in parenting a child with Asperger syndrome: correlates of sense making and benefit finding. (15134791)
2004
25
Cell specificity and properties of the C-3 epimerization of Vitamin D3 metabolites. (15225744)
2004
26
Kleisins: a superfamily of bacterial and eukaryotic SMC protein partners. (12667442)
2003
27
X-inactivation patterns in carriers of X-linked myotubular myopathy. (12899873)
2003
28
Juvenile dermatomyositis associated with lipodystrophy. (17642934)
2003
29
Diversity of mutations and distribution of single nucleotide polymorphic alleles in the human alpha-L-iduronidase (IDUA) gene. (12509712)
2002
30
Intravenous albumin versus hydroxyethyl starch for the prevention of ovarian hyperstimulation in an in-vitro fertilization programme: a prospective randomized placebo controlled study. (11384805)
2001
31
Preferential usage of TCR-Vbeta17 by peripheral and cutaneous T cells in nickel-induced contact dermatitis. (11698485)
2001
32
Intracellular Fas ligand in normal and malignant breast epithelium does not induce apoptosis in Fas-sensitive cells. (11104571)
2000
33
Pathophysiology, clinical features and management of hepatorenal syndrome. (10710816)
1998
34
Localisation of a gene implicated in a severe speech and language disorder. (9462748)
1998
35
A clinico-pathological study of 29 cases of gliosarcoma with special reference to two unique variants. (9378529)
1997
36
Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick disease. (7670466)
1995
37
Analysis of the pH dependence of the neonatal Fc receptor/immunoglobulin G interaction using antibody and receptor variants. (7578107)
1995
38
Prolonged neuromuscular block associated with acute fatty liver of pregnancy and reduced plasma cholinesterase. (8050430)
1994
39
The Pseudomonas aeruginosa homologs of hemC and hemD are linked to the gene encoding the regulator of mucoidy AlgR. (8159168)
1994
40
Molecular cloning of a novel mRNA (neuronatin) that is highly expressed in neonatal mammalian brain. (8024565)
1994
41
Primary gastric adenosarcoma. (8382916)
1993
42
Rearrangements of the RARA and PML genes in a cytogenetic variant of acute promyelocytic leukemia. (7680887)
1993
43
Immunohistochemistry of mesotheliomas. Technique and current diagnostic contribution of immunohistochemical markers. General review]. (8135582)
1993
44
Human-immunodeficiency-virus-type-1-encoded Vpu protein is phosphorylated by casein kinase II. (1541298)
1992
45
Adrenal steroidogenic function in a black and Hispanic population with precocious pubarche. (2152934)
1990
46
Middle ear adenoma. A cytologically uniform neoplasm displaying a variety of architectural patterns. (6476196)
1984
47
Uremic pruritus: a review. (380932)
1979
48
An unusual solitary lesion of secondary syphilis. (6019000)
1967
49
50

Variations for Long Qt Syndrome

About this section

Clinvar genetic disease variations for Long Qt Syndrome:

5 (show all 46)
id Gene Variation Type Significance SNP ID Assembly Location
1RYR2NM_001035.2(RYR2): c.1298T> C (p.Leu433Pro)single nucleotide variantPathogenicrs121918602GRCh37Chr 1, 237617696: 237617696
2KCNH2NM_000238.3(KCNH2): c.2738C> T (p.Ala913Val)single nucleotide variantLikely pathogenic, Pathogenicrs77331749GRCh37Chr 7, 150644921: 150644921
3ANK2NM_001148.4(ANK2): c.4373A> G (p.Glu1458Gly)single nucleotide variantLikely pathogenic, Pathogenicrs72544141GRCh37Chr 4, 114269433: 114269433
4KCNH2NM_000238.3(KCNH2): c.2900dupC (p.Pro968Alafs)duplicationPathogenicrs786204101GRCh37Chr 7, 150644759: 150644759
5KCNH2NM_000238.3(KCNH2): c.3040C> T (p.Arg1014Ter)single nucleotide variantPathogenicrs794728403GRCh37Chr 7, 150644528: 150644528
6KCNH2NM_000238.3(KCNH2): c.2775dupG (p.Pro926Alafs)duplicationPathogenicrs794728455GRCh37Chr 7, 150644884: 150644884
7KCNQ1NM_000218.2(KCNQ1): c.760G> A (p.Val254Met)single nucleotide variantLikely pathogenic, Pathogenicrs120074179GRCh37Chr 11, 2593319: 2593319
8KCNQ1NM_000218.2(KCNQ1): c.1022C> A (p.Ala341Glu)single nucleotide variantPathogenicrs12720459GRCh37Chr 11, 2604765: 2604765
9KCNQ1NM_000218.2(KCNQ1): c.1022C> T (p.Ala341Val)single nucleotide variantPathogenicrs12720459GRCh37Chr 11, 2604765: 2604765
10KCNQ1NM_000218.2(KCNQ1): c.1663C> T (p.Arg555Cys)single nucleotide variantPathogenicrs120074185GRCh37Chr 11, 2797262: 2797262
11KCNQ1NM_000218.2(KCNQ1): c.1552C> T (p.Arg518Ter)single nucleotide variantPathogenicrs17215500GRCh37Chr 11, 2790111: 2790111
12KCNQ1NM_000218.2(KCNQ1): c.1032G> A (p.Ala344=)single nucleotide variantPathogenicrs1800171GRCh37Chr 11, 2604775: 2604775
13KCNQ1NM_000218.2(KCNQ1): c.760G> A (p.Val254Met)single nucleotide variantLikely pathogenic, Pathogenicrs120074179GRCh37Chr 11, 2593319: 2593319
14KCNQ1NM_000218.2(KCNQ1): c.613G> A (p.Val205Met)single nucleotide variantPathogenicrs151344631GRCh37Chr 11, 2592563: 2592563
15KCNQ1NM_000218.2(KCNQ1): c.1032+1G> Asingle nucleotide variantLikely pathogenic, Pathogenicrs397508070GRCh37Chr 11, 2604776: 2604776
16KCNQ1NM_000218.2(KCNQ1): c.1066C> T (p.Gln356Ter)single nucleotide variantPathogenicrs397508072GRCh37Chr 11, 2606475: 2606475
17KCNQ1NM_000218.2(KCNQ1): c.1096C> T (p.Arg366Trp)single nucleotide variantLikely pathogenic, Pathogenicrs199473411GRCh37Chr 11, 2606505: 2606505
18KCNQ1NM_000218.2(KCNQ1): c.1189C> T (p.Arg397Trp)single nucleotide variantLikely pathogenic, Pathogenicrs199472776GRCh37Chr 11, 2608860: 2608860
19KCNQ1NM_000218.2(KCNQ1): c.1354C> T (p.Arg452Trp)single nucleotide variantLikely pathogenic, Pathogenicrs140452381GRCh37Chr 11, 2610045: 2610045
20KCNQ1NM_000218.2(KCNQ1): c.1576A> G (p.Lys526Glu)single nucleotide variantPathogenicrs199472792GRCh37Chr 11, 2790135: 2790135
21KCNQ1NM_000218.2(KCNQ1): c.1588C> T (p.Gln530Ter)single nucleotide variantPathogenicrs397508097GRCh37Chr 11, 2790147: 2790147
22KCNQ1NM_000218.2(KCNQ1): c.1697C> T (p.Ser566Phe)single nucleotide variantLikely pathogenic, Pathogenicrs199472804GRCh37Chr 11, 2798227: 2798227
23KCNQ1NM_000218.2(KCNQ1): c.1781G> A (p.Arg594Gln)single nucleotide variantPathogenicrs199472815GRCh37Chr 11, 2799254: 2799254
24KCNQ1NM_000218.2(KCNQ1): c.532G> A (p.Ala178Thr)single nucleotide variantPathogenicrs120074177GRCh37Chr 11, 2591912: 2591912
25KCNQ1NM_000218.2(KCNQ1): c.535G> A (p.Gly179Ser)single nucleotide variantPathogenicrs199473394GRCh37Chr 11, 2591915: 2591915
26KCNQ1NM_000218.2(KCNQ1): c.560T> C (p.Leu187Pro)single nucleotide variantPathogenicrs199473399GRCh37Chr 11, 2591940: 2591940
27KCNQ1NM_000218.2(KCNQ1): c.585delG (p.Lys196Serfs)deletionPathogenicrs397508120GRCh37Chr 11, 2591965: 2591965
28KCNQ1NM_000218.2(KCNQ1): c.692G> A (p.Arg231His)single nucleotide variantPathogenicrs199472709GRCh37Chr 11, 2593251: 2593251
29KCNQ1NM_000218.2(KCNQ1): c.775C> T (p.Arg259Cys)single nucleotide variantPathogenicrs199472719GRCh37Chr 11, 2593334: 2593334
30KCNQ1NM_000218.2(KCNQ1): c.797T> C (p.Leu266Pro)single nucleotide variantPathogenicrs199473460GRCh37Chr 11, 2594092: 2594092
31KCNQ1NM_000218.2(KCNQ1): c.830C> T (p.Ser277Leu)single nucleotide variantPathogenicrs199472730GRCh37Chr 11, 2594125: 2594125
32KCNQ1NM_000218.2(KCNQ1): c.965C> T (p.Thr322Met)single nucleotide variantLikely pathogenic, Pathogenicrs199472755GRCh37Chr 11, 2604708: 2604708
33KCNE2NM_172201.1(KCNE2): c.79C> T (p.Arg27Cys)single nucleotide variantPathogenicrs74315449GRCh37Chr 21, 35742856: 35742856
34KCNQ1NM_000218.2(KCNQ1): c.1553G> A (p.Arg518Gln)single nucleotide variantPathogenicrs145974930GRCh37Chr 11, 2790112: 2790112
35NM_000218.2(KCNQ1): c.1799C> T (p.Thr600Met)single nucleotide variantPathogenicrs34516117GRCh37Chr 11, 2869001: 2869001
36KCNQ1NM_000218.2(KCNQ1): c.850G> A (p.Glu284Lys)single nucleotide variantPathogenicrs199472734GRCh37Chr 11, 2594145: 2594145
37KCNQ1NM_000218.2(KCNQ1): c.877C> T (p.Arg293Cys)single nucleotide variantPathogenicrs199472737GRCh37Chr 11, 2594172: 2594172
38KCNH2NM_000238.3(KCNH2): c.1810G> A (p.Gly604Ser)single nucleotide variantPathogenicrs199473522GRCh37Chr 7, 150648671: 150648671
39KCNH2NM_000238.3(KCNH2): c.1847A> G (p.Tyr616Cys)single nucleotide variantLikely pathogenic, Pathogenicrs199472946GRCh37Chr 7, 150648634: 150648634
40KCNH2NM_000238.3(KCNH2): c.2131A> G (p.Ile711Val)single nucleotide variantPathogenicrs199473532GRCh37Chr 7, 150648023: 150648023
41KCNH2NM_000238.3(KCNH2): c.2717C> T (p.Ser906Leu)single nucleotide variantPathogenicrs199473435GRCh37Chr 7, 150644942: 150644942
42KCNH2NM_000238.3(KCNH2): c.422C> T (p.Pro141Leu)single nucleotide variantPathogenicrs199472864GRCh37Chr 7, 150656710: 150656710
43KCNH2NM_000238.3(KCNH2): c.934C> T (p.Arg312Cys)single nucleotide variantPathogenicrs199472885GRCh37Chr 7, 150654573: 150654573
44KCNE2NM_172201.1(KCNE2): c.229C> T (p.Arg77Trp)single nucleotide variantPathogenicrs141423405GRCh37Chr 21, 35743006: 35743006
45KCNE2NM_172201.1(KCNE2): c.29C> T (p.Thr10Met)single nucleotide variantLikely pathogenic, Pathogenicrs199473648GRCh37Chr 21, 35742806: 35742806
46KCNE2NM_172201.1(KCNE2): c.80G> A (p.Arg27His)single nucleotide variantPathogenicrs148968498GRCh37Chr 21, 35742857: 35742857

Expression for genes affiliated with Long Qt Syndrome

About this section
Search GEO for disease gene expression data for Long Qt Syndrome.

Pathways for genes affiliated with Long Qt Syndrome

About this section

Pathways related to Long Qt Syndrome according to GeneCards Suite gene sharing:

(show top 50)    (show all 56)
idSuper pathwaysScoreTop Affiliating Genes
19.8ANK2, SCN4B, SCN5A
29.3CALM1, CALM2, CALM3
39.3CALM1, CALM2, CALM3
4
Show member pathways
9.3CALM1, CALM2, CALM3
59.3CALM1, CALM2, CALM3
69.3CALM1, CALM2, CALM3
79.3CALM1, CALM2, CALM3
89.3CALM1, CALM2, CALM3
99.3CALM1, CALM2, CALM3
109.3CALM1, CALM2, CALM3
11
Show member pathways
9.3CALM1, CALM2, CALM3
129.3CALM1, CALM2, CALM3
139.3CALM1, CALM2, CALM3
14
Show member pathways
9.3CALM1, CALM2, CALM3
15
Show member pathways
9.3CALM1, CALM2, CALM3
16
Show member pathways
9.3CALM1, CALM2, CALM3
17
Show member pathways
9.3CALM1, CALM2, CALM3
189.3CALM1, CALM2, CALM3
199.3CALM1, CALM2, CALM3
209.3CALM1, CALM2, CALM3
219.3CALM1, CALM2, CALM3
229.3CALM1, CALM2, CALM3
239.3CALM1, CALM2, CALM3
249.3CALM1, CALM2, CALM3
259.3CALM1, CALM2, CALM3
269.3CALM1, CALM2, CALM3
279.3CALM1, CALM2, CALM3
28
Show member pathways
9.3CALM1, CALM2, CALM3
299.0CALM1, CALM2, CALM3, KCNJ2
30
Show member pathways
9.0CALM1, CALM2, CALM3, RYR2
319.0CALM1, CALM2, CALM3, RYR2
32
Show member pathways
9.0CALM1, CALM2, CALM3, RYR2
339.0CALM1, CALM2, CALM3, CAV3
34
Show member pathways
8.9AKAP9, CALM1, CALM2, CALM3
35
Show member pathways
8.9AKAP9, CALM1, CALM2, CALM3
368.8CAV3, KCNH2, KCNQ1, RYR2, SCN4B, SCN5A
37
Show member pathways
8.7CALM1, CALM2, CALM3, RYR2, SNTA1
38
Show member pathways
8.6CALM1, CALM2, CALM3, KCNJ5, RYR2
39
Show member pathways
8.6CALM1, CALM2, CALM3, KCNE2, KCNJ2, KCNQ1
40
Show member pathways
8.5CALM1, CALM2, CALM3, RYR2, TRDN
41
Show member pathways
8.4CALM1, CALM2, CALM3, KCNJ5, SCN4B, SCN5A
42
Show member pathways
8.4CALM1, CALM2, CALM3, KCNJ2, KCNJ5, RYR2
43
Show member pathways
8.1CALM1, CALM2, CALM3, KCNE1, KCNQ1, RYR2
44
Show member pathways
8.0KCND2, KCND3, KCNH2, KCNJ2, KCNJ5, KCNQ1
457.4ANK2, KCND3, KCNE1, KCNE2, KCNH2, KCNJ2
46
Show member pathways
7.4CALM1, CALM2, CALM3, KCND2, KCNJ2, KCNJ5
47
Show member pathways
6.5AKAP9, CALM1, CALM2, CALM3, KCND2, KCND3
48
Show member pathways
6.4AKAP9, CALM1, CALM2, CALM3, KCND2, KCND3
496.1AKAP9, CALM1, CALM2, CALM3, KCND2, KCND3
50
Show member pathways
4.9AKAP9, CALM1, CALM2, CALM3, CAV3, KCND2

GO Terms for genes affiliated with Long Qt Syndrome

About this section

Cellular components related to Long Qt Syndrome according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1voltage-gated sodium channel complexGO:000151810.6SCN4B, SCN5A
2intercalated discGO:001470410.0ANK2, CAV3, KCNJ2
3vesicleGO:00319829.6CALM1, CALM2, CALM3
4voltage-gated potassium channel complexGO:00080769.1AKAP9, KCND2, KCNJ5
5plasma membraneGO:00058866.8CALM1, CALM3, KCND2, KCND3, KCNE1, KCNE2

Biological processes related to Long Qt Syndrome according to GeneCards Suite gene sharing:

(show top 50)    (show all 56)
idNameGO IDScoreTop Affiliating Genes
1atrial cardiac muscle cell action potentialGO:008601410.7ANK2, KCNQ1
2membrane depolarization during SA node cell action potentialGO:008604610.7ANK2, SCN5A
3regulation of potassium ion transmembrane transportGO:190137910.7KCNE1, KCNH2
4regulation of cardiac muscle contraction by calcium ion signalingGO:001088210.6ANK2, RYR2
5cardiac muscle cell action potential involved in contractionGO:008600210.5KCNE1, KCNE2, SCN5A
6potassium ion importGO:001010710.5KCNE2, KCNJ2
7regulation of membrane repolarizationGO:006030610.5KCNH2, KCNJ2, KCNQ1
8regulation of sodium ion transmembrane transporter activityGO:200064910.4CAV3, SCN4B
9potassium ion transmembrane transportGO:007180510.4KCNE2, KCNH2, KCNJ2
10positive regulation of potassium ion transmembrane transporter activityGO:190101810.4AKAP9, ANK2
11negative regulation of delayed rectifier potassium channel activityGO:190226010.4KCNE1, KCNE2, KCNQ1
12membrane depolarization during cardiac muscle cell action potentialGO:008601210.4KCNJ2, SCN4B, SCN5A
13regulation of cardiac muscle cell contractionGO:008600410.3ANK2, KCNJ2, SCN5A
14positive regulation of potassium ion transmembrane transportGO:190138110.3KCNE1, KCNH2, KCNJ2, KCNQ1
15sarcoplasmic reticulum calcium ion transportGO:007029610.3ANK2, RYR2
16release of sequestered calcium ion into cytosol by sarcoplasmic reticulumGO:001480810.2RYR2, TRDN
17potassium ion exportGO:007143510.1KCND3, KCNE2, KCNH2
18cardiac conductionGO:00613379.9AKAP9, KCNE1, KCNE2, KCNQ1
19positive regulation of phosphoprotein phosphatase activityGO:00325169.7CALM1, CALM2, CALM3
20regulation of high voltage-gated calcium channel activityGO:19018419.7CALM1, CALM2, CALM3
21activation of phospholipase C activityGO:00072029.7CALM1, CALM2, CALM3
22rhodopsin mediated signaling pathwayGO:00160569.7CALM1, CALM2, CALM3
23positive regulation of protein dephosphorylationGO:00353079.7CALM1, CALM2, CALM3
24negative regulation of peptidyl-threonine phosphorylationGO:00108019.7CALM1, CALM2, CALM3
25positive regulation of peptidyl-threonine phosphorylationGO:00108009.7CALM1, CALM2, CALM3
26positive regulation of cyclic-nucleotide phosphodiesterase activityGO:00513439.7CALM1, CALM2, CALM3
27negative regulation of ryanodine-sensitive calcium-release channel activityGO:00603159.7CALM1, CALM2, CALM3
28platelet degranulationGO:00025769.6CALM1, CALM2, CALM3
29inositol phosphate metabolic processGO:00436479.6CALM1, CALM2, CALM3
30nitric oxide metabolic processGO:00462099.6CALM1, CALM2, CALM3
31response to calcium ionGO:00515929.6CALM1, CALM2, CALM3
32glycogen catabolic processGO:00059809.6CALM1, CALM2, CALM3
33regulation of cell communication by electrical coupling involved in cardiac conductionGO:19018449.6CALM1, CALM2, CALM3
34phosphorylationGO:00163109.5CALM1, CALM2, CALM3
35regulation of cytokinesisGO:00324659.5CALM1, CALM2, CALM3
36regulation of heart rate by cardiac conductionGO:00860919.5AKAP9, ANK2, KCNE2, KCNH2, SCN4B, SCN5A
37ventricular cardiac muscle cell action potentialGO:00860059.5ANK2, CAV3, KCNH2, KCNQ1, RYR2, SCN5A
38phototransduction, visible lightGO:00076039.5CALM1, CALM2, CALM3
39calcium-mediated signalingGO:00197229.5CALM1, CALM2, RYR2
40positive regulation of protein serine/threonine kinase activityGO:00719029.4CALM1, CALM2, CALM3
41regulation of ventricular cardiac muscle cell membrane repolarizationGO:00603079.3ANK2, KCNE1, KCNE2, KCNH2, KCNQ1, SCN4B
42MAPK cascadeGO:00001659.1AKAP9, CALM1, CALM2, CALM3
43regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulumGO:00108809.1CALM1, CALM2, CALM3, TRDN
44activation of MAPKK activityGO:00001869.0AKAP9, CALM1, CALM2, CALM3
45response to amphetamineGO:00019759.0CALM1, CALM2, CALM3
46vascular endothelial growth factor receptor signaling pathwayGO:00480108.9AKAP9, CALM1, CALM2, CALM3
47muscle contractionGO:00069368.9CALM1, CALM2, CALM3, CAV3, TRDN
48ion transportGO:00068118.8KCND2, KCNE1, KCNH2, KCNQ1, RYR2, SCN5A
49regulation of cardiac muscle contractionGO:00551178.8ANK2, CALM1, CALM2, CALM3, CAV3, RYR2
50axon guidanceGO:00074118.4AKAP9, ANK2, CALM1, CALM2, CALM3, SCN5A

Molecular functions related to Long Qt Syndrome according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1voltage-gated potassium channel activityGO:000524910.5KCNE2, KCNH2
2type 3 metabotropic glutamate receptor bindingGO:00318009.4CALM1, CALM2
3Ras guanyl-nucleotide exchange factor activityGO:00050889.3CALM1, CALM2, CALM3
4calcium-dependent protein bindingGO:00483069.2CALM1, CALM2, CALM3

Sources for Long Qt Syndrome

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet